The taintedblood Timeline - what really happened...
- The possibility is considered of withdrawing clotting factor concentrates from the market and replacing them with cryoprecipitate. It is concluded that this is not feasible in the UK on grounds of supply. (Minutes Agenda Point 5.3)
- The possibility is considered of withdrawing US preparations from the UK. It is concluded that this is not at present feasible on grounds of supply. Moreover, the perceived level of risk does not at present justify serious consideration of such a solution. (Minutes Agenda Point 5.4)
"We understand that treatment with cryoprecipitate carried a number of disadvantages compared to pooled clotting factors."
"It required the patient to be treated in hospital"
All rights reserved